Breaking News Instant updates and real-time market news.

CVS

CVS Health

$52.88

-0.05 (-0.09%)

, ALGN

Align Technology

$299.90

2.78 (0.94%)

10:04
04/25/19
04/25
10:04
04/25/19
10:04

Smile Direct, CVS news 'good' for Align Technology, says Baird

Smile Direct Club announced an expanded agreement with CVS (CVS) and an agreement with Aetna Dental, which Baird analyst Jeff Johnson could likely drive additional clear aligner awareness, something that should be good for the industry, and, specifically Align Technology (ALGN), where early efforts with Walgreens (WBA) "seem to be developing" and where traction remains strong through DSOs. The analyst maintains an Outperform rating and $336 price target on Align Technology shares.

CVS

CVS Health

$52.88

-0.05 (-0.09%)

ALGN

Align Technology

$299.90

2.78 (0.94%)

WBA

Walgreens Boots Alliance

$53.02

-0.45 (-0.84%)

  • 01

    May

  • 15

    May

  • 16

    May

  • 19

    May

  • 05

    Jun

CVS CVS Health
$52.88

-0.05 (-0.09%)

04/18/19
PIPR
04/18/19
NO CHANGE
Target $73
PIPR
Overweight
Tabula Rasa weakness brings 'compelling entry point,' says Piper Jaffray
Piper Jaffray analyst Sean Wieland is "incrementally more positive" on Tabula Rasa HealthCare's (TRHC) growth outlook after traveling with the company's CFO Brian Adams. CVS Health (CVS) provides a "strong validation" of Tabula Rasa's value proposition, and multiple opportunities should result in a higher margin product mix, Wieland tells investors in a research note. Further, the analyst believes the recent weakness in the stock has created a "compelling entry point." He reiterates an Overweight rating on Tabula Rasa HealthCare with a $73 price target.
04/17/19
GUGG
04/17/19
INITIATION
GUGG
Buy
CVS Health assumed with a Buy at Guggenheim
Guggenheim analyst Glen Santangelo assumed coverage of CVS Health with a Buy rating and $63 price target, lowered from a previous price target of $85. The analyst is "excited about the strategic repositioning of the company and the long-term opportunities for the new model," but noted that he "underestimated the structural and integration issues facing the business." That said, Santangelo believes that much of the damage to the stock is already done, and believes CVS Health is a good fit for long-term investors that can handle near-term volatility.
04/17/19
SPHN
04/17/19
NO CHANGE
SPHN
Issues facing healthcare sector now 'modest' compared to 2008-10, says Stephens
Stephens analyst Scott Fidel noted that the managed care group has sharply underperformed the S&P 500 over the last month amid "political rhetoric" around point-of-sale drug rebates and Medicare for all policy proposals, though he believes the issues facing the sector right now "seem modest in comparison" to the "dark days of 2008-2010." While recent Medicare for all proposals have rattled investors, "they will face enormous uphill battles," Fidel tells investors. Hospital stocks have outperformed MCOs year-to-date, but the group declined about 9% yesterday and underperformed the MCO group, which Fidel attributes to acknowledgement by industry bellwether UnitedHealth (UNH) of the significant disruptive nature of Medicare for all, which may have sparked additional fears, as well as one less calendar day being called out by UnitedHealth as benefiting Q1 MLRs and Johnson & Johnson's (JNJ) earnings call commentary on declining sequential hospital admissions from Q4. Publicly traded companies in the hospital space include Community Health (CYH), HCA Healthcare (HCA), LifePoint (LPNT), Tenet (THC) and Universal Health (UHS). Publicly traded companies in the managed care space include Anthem (ANTM), CVS Health (CVS), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
04/15/19
04/15/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. CVS Health (CVS) downgraded to Perform from Outperform at Oppenheimer with analyst Michael Wiederhorn saying he views it as more of a long-term opportunity given the potential timeline to execute on its strategy and the near-term legacy business challenges. 2. Infosys (INFY) downgraded to Hold from Buy at Deutsche Bank and Investec, to Reduce from Neutral at Nomura Instinet, to Underperform from Neutral at Credit Suisse, to Equal Weight from Overweight at Morgan Stanley, and to Neutral from Buy at Citi and BofA/Merrill. 3. Celanese (CE) downgraded to Hold from Buy at Deutsche Bank with analyst David Begleiter saying the company's leadership transition creates uncertainty. 4. Alliance Data (ADS) downgraded to Underweight from Equal Weight at Stephens and to Market Perform from Outperform at BMO Capital. 5. Wells Fargo (WFC) downgraded to Neutral from Conviction Buy at Goldman Sachs, to In Line from Outperform at Evercore ISI, and to Neutral from Buy at BofA/Merrill and Buckingham. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ALGN Align Technology
$299.90

2.78 (0.94%)

04/23/19
PIPR
04/23/19
NO CHANGE
PIPR
Piper sees Q1 revenue upside for Inogen, Teleflex, Align Technology
Piper Jaffray analyst Matt O'Brien says his deep dive into the MedTech companies exploring the direct-to-consumer sales channel came up "most compelling" for Inogen (INGN), Teleflex (TFX) and Align Technology (ALGN). Website traffic at these companies is at or near three-year highs and historical trends suggest a high likelihood of revenue upside in Q1, O'Brien tells investors in a research note. The analyst also found DexCom's (DXCM) website traffic to be at three-year highs.
04/25/19
PIPR
04/25/19
NO CHANGE
Target $350
PIPR
Overweight
Align Technology price target raised to $350 from $300 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for Align Technology to $350 from $300 saying the company posted a Q1 top- and bottom-line beat and introduced above-Street Q2 revenue guidance. Sentiment on the shares should continue improving as the quarter demonstrated the company's momentum in key growth drivers of North America utilization, international, and teen along with "potentially stabilizing" pricing should set up Align for "multiple years of top-tier growth," O'Brien tells investors in a post-earnings research note. While the analyst gets the sense that the company will invest heavily again this year to support future growth, he believes margin pressure may not be as bad as he feared last quarter. O'Brien reiterates an Overweight rating on Align Technology.
04/25/19
LEHM
04/25/19
NO CHANGE
Target $355
LEHM
Overweight
Align Technology price target raised to $355 from $335 at Barclays
Barclays analyst Steve Valiquette raised his price target for Align Technology to $355 from $335 saying the company's Q1 results checked the box in every key category. The "timing to invest in Align could not be much better, particularly for investors looking for healthcare franchises that are relatively shielded from Medicare for All risk," Valiquette tells investors in a post-earnings research note. He keeps an Overweight rating on the shares.
04/25/19
FBCO
04/25/19
NO CHANGE
Target $316
FBCO
Outperform
Align Technology price target raised to $316 from $305 at Credit Suisse
Credit Suisse analyst Erin Wilson Wright raised her price target for Align Technology to $316 from $305 saying that while Q1 and initial Q2 guidance was admittedly not clean, with several one-time variables, she is encouraged by the latest volume and ASP upside. The analyst reiterates an Outperform rating on the shares.
WBA Walgreens Boots Alliance
$53.02

-0.45 (-0.84%)

04/03/19
04/03/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Caterpillar (CAT) downgraded to Hold from Buy at Deutsche Bank with analyst Chad Dillard saying the biggest risk to the bull case for Caterpillar is if its backlog growth turns negative, "and it is becoming increasingly clear that it will within this next quarter." 2. Dunkin' Brands (DNKN) downgraded to Market Perform from Outperform at BMO Capital with analyst Andrew Strelzik saying that while he remains positive on the company's underlying fundamentals over the long term, he sees risk/reward at current levels as "less persuasive." 3. Tallgrass Energy (TGE) downgraded to Neutral from Buy at Goldman Sachs with analyst Michael Lapides citing the stock's recent outperformance and also warns that its Rockies Express Pipeline natural gas pipeline and Pony Express crude oil pipeline contract roll-offs pose "overhangs," even though the "volume growth out of Bakken, Niobrara, and Powder River Basin could offset this over time." 4. Walgreens Boots Alliance (WBA) downgraded to Hold from Buy at Loop Capital with analyst Andrew Wolf citing the company's disappointing Q2 earnings and FY19 guidance announced yesterday "driven by significantly lower-than-forecasted gross margin resulting from increased pharmacy reimbursement rate pressure in the U.S." 5. Alcoa (AA) downgraded to Neutral from Buy at BofA/Merrill with analyst Timna Tanners saying she now sees limited free cash flow payments by Alcoa to upstream AWAC joint-venture partner Alumina Ltd, potential excess alumina/bauxite supply, and potential price risks from the Alunorte refinery restarting, the world's largest refinery. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/18/19
04/18/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Morgan Stanley (MS) downgraded to Neutral from Buy at Citi with analyst Keith Horowitz saying Morgan Stanley reported "strong" Q1 results but the shares are fairly valued. 2. Snap (SNAP) downgraded to Negative from Mixed at Vertical Group and to Neutral from Outperform at Wedbush. 3. Rite Aid (RAD) downgraded with a Sell from Neutral at Guggenheim while Walgreens Boots Alliance (WBA) was downgraded with a Neutral from Buy. 4. CF Industries (CF) downgraded to Underperform from Buy at BofA/Merrill with analyst Steve Byrne saying he has spoken with 10 key channel contacts in the Cornbelt and several commented that never in their 30-plus year careers have they seen fertilizer applications this far behind, mainly due to the weather. 5. FMC Corporation (FMC) downgraded to Sector Perform from Outperform at RBC Capital with analyst Arun Viswanathan citing the "uncertainty of Rynaxypyr and Cyazypyr patent expiration" as well as the reduced multiple from the recent lithium separation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/17/19
GUGG
04/17/19
DOWNGRADE
Target $59
GUGG
Neutral
Walgreens Boots Alliance assumed with a Neutral from Buy at Guggenheim
04/17/19
GUGG
04/17/19
DOWNGRADE
Target $59
GUGG
Neutral
Walgreens Boots Alliance assumed with a Neutral from Buy at Guggenheim
Guggenheim analyst Glen Santangelo assumed coverage of Walgreens Boots Alliance and downgraded the shares to Neutral from the firm's Buy rating under analyst John Heinbockel. He lowered his price target for the stock to $59 from $75. The analyst is concerned about the continuing structural pressures facing the retail pharmacy industry. Further, the evolution of Walgreens' competitive landscape "will continue to make things difficult for the company," Santangelo tells investors in a research note.

TODAY'S FREE FLY STORIES

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:51
06/25/19
06/25
17:51
06/25/19
17:51
Hot Stocks
FedEx says has made no pricing changes »

Says business realignment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:46
06/25/19
06/25
17:46
06/25/19
17:46
Hot Stocks
FedEx says international commercial team still poised for growth »

Says TNT Express…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:43
06/25/19
06/25
17:43
06/25/19
17:43
Hot Stocks
FedEx says global trade picture 'less than ideal' »

Says "all-in"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:38
06/25/19
06/25
17:38
06/25/19
17:38
Hot Stocks
FedEx calls FY20 a 'transition year' »

Says FY20 a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:37
06/25/19
06/25
17:37
06/25/19
17:37
Hot Stocks
FedEx says intends to substantially grow e-commerce business »

Sees FedEx Freight will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

CNX

CNX Resources

$6.83

-0.345 (-4.81%)

17:36
06/25/19
06/25
17:36
06/25/19
17:36
Hot Stocks
CNX Resources director Bernard Lanigan purchases 36,200 shares of company stock »

CNX Resources director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$24.96

0.21 (0.85%)

17:32
06/25/19
06/25
17:32
06/25/19
17:32
Hot Stocks
TechnipFMC confirms settlement with U.S., Brazilian enforcement authorities »

TechnipFMC has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Aug

MO

Altria Group

$48.80

0.31 (0.64%)

, BTI

British American Tobacco

$35.76

0.56 (1.59%)

17:25
06/25/19
06/25
17:25
06/25/19
17:25
Periodicals
San Francisco votes to ban sale of e-cigarettes, AP reports »

San Francisco, California…

MO

Altria Group

$48.80

0.31 (0.64%)

BTI

British American Tobacco

$35.76

0.56 (1.59%)

PM

Philip Morris

$78.85

1.02 (1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$53.69

0.57 (1.07%)

17:16
06/25/19
06/25
17:16
06/25/19
17:16
Recommendations
CVS Health analyst commentary at Tigress Financial »

Tigress Financial sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$24.96

0.21 (0.85%)

17:15
06/25/19
06/25
17:15
06/25/19
17:15
Hot Stocks
TechnipFMC, subsidiary to pay $296M to resolve foreign bribery charges »

TechnipFMC and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Aug

ORRF

Orrstown Financial

$21.93

0.22 (1.01%)

17:11
06/25/19
06/25
17:11
06/25/19
17:11
Hot Stocks
Orrstown Financial names Thomas Brugger EVP and CFO »

Orrstown Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

17:07
06/25/19
06/25
17:07
06/25/19
17:07
Hot Stocks
Micron says it has mitigated 90% of China tariff impact »

Says U.S. tariffs on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

AGN

Allergan

$162.60

32.95 (25.41%)

, ABBV

AbbVie

$65.63

-12.78 (-16.30%)

17:07
06/25/19
06/25
17:07
06/25/19
17:07
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

Stocks muddled through a…

AGN

Allergan

$162.60

32.95 (25.41%)

ABBV

AbbVie

$65.63

-12.78 (-16.30%)

TMUS

T-Mobile

$74.56

-0.98 (-1.30%)

S

Sprint

$6.82

-0.04 (-0.58%)

DISH

Dish

$37.80

-0.79 (-2.05%)

LEN

Lennar

$48.24

-3.17 (-6.17%)

FDX

FedEx

$156.00

-4.88 (-3.03%)

UPS

UPS

$97.11

-2.58 (-2.59%)

FB

Facebook

$188.87

-3.69 (-1.92%)

PYX

Pyxus

$17.06

3.635 (27.09%)

GRUB

GrubHub

$76.01

3.96 (5.50%)

ALDX

Aldeyra

$6.21

-0.87 (-12.29%)

W

Wayfair

$144.54

-7.925 (-5.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 09

    Jul

  • 10

    Jul

  • 16

    Jul

  • 24

    Jul

  • 30

    Jul

  • 31

    Jul

  • 16

    Sep

  • 13

    Nov

AITB

AIT Therapeutics

$5.33

0.06 (1.14%)

17:05
06/25/19
06/25
17:05
06/25/19
17:05
Hot Stocks
AIT Therapeutics plans to file PMA submission with FDA for PPHN with AirNOvent »

On track to file a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

17:03
06/25/19
06/25
17:03
06/25/19
17:03
Earnings
Micron sees Q4 EPS 45c +/- 7c, consensus 78c »

Sees Q4 revenue $4.5B +/-…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

AITB

AIT Therapeutics

$5.33

0.06 (1.14%)

17:00
06/25/19
06/25
17:00
06/25/19
17:00
Earnings
AIT Therapeutics reports Q4 EPS (49c), consensus 28c »

Reports Q4 revenue $7.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

16:48
06/25/19
06/25
16:48
06/25/19
16:48
Hot Stocks
Micron says it can resume shipping a certain subset of products to Huawei »

Says expects healthy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

AVAV

AeroVironment

$61.41

-0.52 (-0.84%)

16:42
06/25/19
06/25
16:42
06/25/19
16:42
Hot Stocks
AeroVironment down 9.5% to $55.50 after Q4 results, FY20 guidance »

The midpoint of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

BBVA

Banco Bilbao

$5.52

-0.05 (-0.90%)

16:40
06/25/19
06/25
16:40
06/25/19
16:40
Syndicate
Breaking Syndicate news story on Banco Bilbao »

Banco Bilbao files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

CRTO

Criteo

$18.00

-0.05 (-0.28%)

16:39
06/25/19
06/25
16:39
06/25/19
16:39
Hot Stocks
Criteo COO Mollie Spilman to leave company »

Criteo S.A. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$30.68

0.17 (0.56%)

16:37
06/25/19
06/25
16:37
06/25/19
16:37
Hot Stocks
Kraft Heinz accelerates new CEO start date to June 25 »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$144.12

-5.99 (-3.99%)

16:34
06/25/19
06/25
16:34
06/25/19
16:34
Periodicals
Spotify chief revenue officer Brian Benedik to depart, The Information reports »

Spotify's chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:34
06/25/19
06/25
16:34
06/25/19
16:34
General news
API crude inventories for week of June 21 »

API reports that crude…

GBCI

Glacier Bancorp

$39.23

-0.06 (-0.15%)

16:34
06/25/19
06/25
16:34
06/25/19
16:34
Hot Stocks
Glacier Bancorp raises dividend to 27c from 26c »

Glacier Bancorp declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

NSRGY

Nestle

$0.00

(0.00%)

, NVS

Novartis

$92.37

-0.41 (-0.44%)

16:33
06/25/19
06/25
16:33
06/25/19
16:33
Periodicals
Nestle, Novartis among multinationals at risk of London trading ban, WSJ says »

Trading in…

NSRGY

Nestle

$0.00

(0.00%)

NVS

Novartis

$92.37

-0.41 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.